Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received be request for issue of duplicate Share Certificates from Shareholders, Ramaniklal Amarprasad Passawala; Suryakanta Ramaniklal Passawala (Folio No: 0156028), further details attached.
The above information is a part of company’s filings submitted to BSE.
